Found: 25
Select item for more details and to access through your institution.
Identification and Validation of a Hypoxia and Glycolysis Prognostic Signatures in Lung Adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1568, doi. 10.7150/jca.91504
- By:
- Publication type:
- Article
Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: Investigating POLE2 in bladder cancer progression and cisplatin resistance.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1734, doi. 10.7150/jca.93023
- By:
- Publication type:
- Article
UBE2C is a diagnosis and therapeutic biomarker involved in immune infiltration of cancers including lung adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1701, doi. 10.7150/jca.92473
- By:
- Publication type:
- Article
A Potential biomarker for the early diagnosis of OSCC: saliva and serum PrP<sup>C</sup>.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1593, doi. 10.7150/jca.92489
- By:
- Publication type:
- Article
Exosome-mediated delivery of artificial circular RNAs for gene therapy of bladder cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1770, doi. 10.7150/jca.90620
- By:
- Publication type:
- Article
Gene polymorphisms of METTL5 and METTL16 are related to epithelial ovarian cancer risk in South China: A three-center case-control study.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1762, doi. 10.7150/jca.90379
- By:
- Publication type:
- Article
Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon Adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1750, doi. 10.7150/jca.91089
- By:
- Publication type:
- Article
LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1718, doi. 10.7150/jca.91184
- By:
- Publication type:
- Article
FAM72A promotes glioma progression by regulating mitophagy through the Pink1/Parkin signaling pathway: Erratum.
- Published in:
- 2024
- Publication type:
- Correction Notice
CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis: Erratum.
- Published in:
- 2024
- Publication type:
- Correction Notice
The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1668, doi. 10.7150/jca.92689
- By:
- Publication type:
- Article
An Investigation of the Immune Microenvironment and Genome during Lung Adenocarcinoma Development.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1687, doi. 10.7150/jca.92101
- By:
- Publication type:
- Article
Inside anticancer therapy resistance and metastasis. Focus on CD36.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1675, doi. 10.7150/jca.90457
- By:
- Publication type:
- Article
Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1657, doi. 10.7150/jca.91064
- By:
- Publication type:
- Article
The Emerging Function and Promise of tRNA-Derived Small RNAs in Cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1642, doi. 10.7150/jca.89219
- By:
- Publication type:
- Article
Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1551, doi. 10.7150/jca.92327
- By:
- Publication type:
- Article
HES4 is a potential biomarker for bladder cancer: a Mendelian randomization study.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1624, doi. 10.7150/jca.92657
- By:
- Publication type:
- Article
Age-related Disparities in Pan-Cancer Mortality and Causes of Death: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1613, doi. 10.7150/jca.91758
- By:
- Publication type:
- Article
The METTL3/miR-196a Axis Predicts Poor Prognosis in Non-small Cell Lung Cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1603, doi. 10.7150/jca.92968
- By:
- Publication type:
- Article
Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1583, doi. 10.7150/jca.91716
- By:
- Publication type:
- Article
Modulation of immune-responses by DSF/Cu enhances the anti-tumor effects of DTX for metastasis breast cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1523, doi. 10.7150/jca.89120
- By:
- Publication type:
- Article
Integrated Bioinformatics and Experimental Analysis of Long Noncoding RNA Associated-ceRNA as Prognostic Biomarkers in Advanced Stomach Adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1536, doi. 10.7150/jca.89526
- By:
- Publication type:
- Article
High CD204<sup>+</sup> tumor-associated macrophage density predicts a poor prognosis in patients with clear cell renal cell carcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1511, doi. 10.7150/jca.91928
- By:
- Publication type:
- Article
LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1498, doi. 10.7150/jca.91984
- By:
- Publication type:
- Article
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002).
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1487, doi. 10.7150/jca.91675
- By:
- Publication type:
- Article